This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Nov. 1, 2012

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

Fall Managed Care Forum
Nov. 8-9
Bellagio Hotel

Click Here to view the Journal of Managed Care Medicine

Click Here to view our Complimentary Online CME/CEU Webcasts

Announcing the NAMCP Medical Directors Lung Cancer Resource Center. Click here to visit the website.

Be sure to check out the study results of Verinata's Non-Invasive Prenatal Technology. Click here to view the press release.

Click here to check out the "Latest in Clinical Nutrition" DVD available for purchase now!



When genetic engineering came of age
Forbes    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The 30th anniversary recently came of an event that kicked off an important new era in drug therapies — the approval by the FDA of human insulin synthesized in genetically engineered bacteria. The saga is remarkable in several ways, not least of which is that although both the drugmakers and regulators were exploring unknown territory, the development of the drug and its regulatory review progressed smoothly and rapidly. More

Study: Gene may be tied to both smoking and ADHD
HealthDay News via Doctors Lounge    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Smoking and attention-deficit/hyperactivity disorder share a common genetic risk factor, and childhood ADHD may increase the likelihood of smoking later in life, a new study suggests. People with ADHD are more likely to start smoking early and to smoke twice as much as those without ADHD, the researchers noted. More

Earn your MS in Nursing Online

Nursing@Georgetown is a Master’s in Nursing program delivered online by Georgetown University’s renowned School of Nursing & Health Studies. These programs are designed to help the next generation of nursing leaders achieve their career goals while improving the health and well-being of all people. MORE

DNA experiment yields great promise and high ethical risks
Religion News Service via The Washington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Future generations could be stripped of mutations like hereditary blindness or maternal diabetes, after a breakthrough study at Oregon Health & Science University. But the new technique is also one short step from genetic design of future generations, said Marcy Darnovksy of the California-based Center for Genetics and Society. More

 Biotech/Diagnostics/Personalized Medicine

Proton therapy treatment preserves quality of life for men with prostate cancer
Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Two studies led by The University of Texas MD Anderson Cancer Center have found that proton therapy preserves the quality of life, specifically urinary and bowel function, in men treated with this targeted radiation modality for prostate cancer. More

Experience Healthy Work-Life Balance

Concentra is a proven leader in occupational medicine, treating 1 in 7 work-related injuries in the US. Concentra physicians work consistent schedules with minimal to no on-call shifts in an environment designed to allow more time for patient care—and more time for a healthy work-life balance.

Study identifies genetic variations as predictors of prostate cancer-related fatigue
The Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers at Moffitt Cancer Center and the University of South Florida have found that men with prostate cancer who receive androgen deprivation therapy may predictably suffer from fatigue if they have single nucleotide polymorphisms in three pro-inflammatory genes. The discovery highlights the importance of personalized medicine, in which therapies are tailored to a patient's genetic profile. More

 Regenerative Medicine

Pediatricians OK embryonic stem cell research
MedPage Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Citing its potential for use in pediatric diseases, the American Academy of Pediatrics has thrown its support behind human embryonic stem cell research. The research has possible implications for certain childhood diseases, including hypoxic-ischemic encephalopathy, bone marrow failure syndromes, leukemia, congenital heart disease, neonatal lung disease and type 1 diabetes, researchers said. More

Targeting stem cells helps in brain cancer
MedPage Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Glioblastoma patients who underwent high-dose radiation to the purported spawning grounds of cancer stem cells in the brain appear to achieve longer survival, researchers said. More

 Emerging Medical Technologies

New bandages peel off without tugging on sensitive skin
Medgadget    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers from MIT and Harvard Medical School took on the challenge of creating a gentler bandage. Their first step was realizing that the adhesive can be left on the skin as long as the bandage itself is removed. To implement the separation of the bandage from the adhesive they introduced an intermediate layer of silicone that peels off the adhesive. More

Medical implants receive little oversight in US and Europe
The Morning Call    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A joint investigation released by the Daily Telegraph and the British Medical Journal showed poor oversight by European Union agencies responsible for certifying the safety of new medical implants. More

 Managed Healthcare News

Cialis receives EU approval for new use
The Associated Press via USA Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The European Union has approved Eli Lilly and Co.'s erectile dysfunction drug Cialis to treat symptoms tied to an enlarged prostate. Lilly said the commission approved a 5-milligram, once-daily dose to treat the signs and symptoms of the condition also known as benign prostatic hyperplasia. More

Insurance industry dislikes healthcare law, but sees repeal unnerving
The Associated Press via The Washington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Although the health insurance industry hates parts of President Barack Obama's healthcare law, major outfits such as UnitedHealth Group and BlueCross Blue Shield also stand to rake in billions of dollars from new customers who'll get health insurance under the law. The companies already have invested tens of millions to carry it out. More

 FDA: New Treatments and Technology

FDA warns to keep nasal sprays, eye drops away from children
Medical Daily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Over the counter nasal sprays or eye drops must be kept out of children's reach as these can cause some serious damage to a child's health, the Food and Drug Administration warned. More

FDA approves topical suspension for body plaque psoriasis
Healio    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The FDA has approved a 0.005 percent calcipotriene and 0.064 percent betamethasone dipropionate topical suspension for the treatment of body plaque psoriasis, according to a news release. More

"According to the American Cancer Society, colorectal cancer is one of the leading causes of cancer-related deaths in the country. Early diagnosis can often lead to a complete cure."


Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Christine Kraly, Content Editor, 469.420.2685   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Oct. 25, 2012
Oct. 18, 2012
Oct. 11, 2012
Oct. 4, 2012

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063